Acupuncture with immunotherapy for older lung cancer patients
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether adding electroacupuncture (a gentle, needle-based therapy) to a standard immunotherapy drug (PD-1 inhibitor) can help older adults with advanced lung cancer. It may improve treatment response and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years old or older.
- You have advanced non-small cell lung cancer (stage IIIB or IV) that has no treatable genetic mutations like EGFR or ALK.
- Your cancer cells have a PD-L1 score of 1% or higher (a protein marker that helps your immune system attack the cancer).
- You are generally able to take care of yourself (ECOG score 0–2) and your doctor thinks you have at least 3 months to live.
- You have not had another cancer in the last 5 years, and you do not have untreated brain metastases, severe organ problems, active infections, or autoimmune diseases.
- You are willing to follow the study plan and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding electroacupuncture to a PD-1 inhibitor (a type of immunotherapy) can help people with advanced non-small cell lung cancer who have limited activity levels. It may improve treatment response and quality of life.
This trial explores whether adding electroacupuncture (a gentle needle treatment with mild electric pulses) to standard immunotherapy after lung cancer surgery can help prevent the cancer from coming back. It is designed for people with early-stage non-small cell lung cancer who have already had chemotherapy.
This trial tests if adding electroacupuncture at a specific point (ST36, below the knee) to standard chemotherapy and immunotherapy can help people with lung cancer. It aims to improve treatment outcomes and quality of life.
This study tests whether adding electro-acupuncture (a gentle type of acupuncture with mild electrical pulses) to standard first-line immunotherapy and chemotherapy can help people with advanced non-small cell lung cancer. It aims to see if this combination improves quality of life and overall treatment outcomes.
This study tests a milder chemotherapy combined with an immunotherapy drug (anti-PD-1) as the first treatment for advanced lung cancer in older or frailer adults. It aims to see if this approach works better with fewer side effects.
This trial tests if adding acupuncture to standard immunotherapy and chemotherapy helps people with advanced lung cancer. It is for those who have not had treatment before and whose tumors have low PD-L1 levels.
Hear when a new Elderly Patients (>65 Years) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.